Search bioRxivSearch

bioRxiv · 10.1101/462341

A proof of concept for a syndromic surveillance system based on routine ambulance records in the South-West of England, for the influenza season 2016/17.

Abstract

The introduction of electronic patient records in the ambulance service provides new opportunities to monitor the population. Most patients presenting to British ambulance services are discharged at scene. Ambulance records are therefore an ideal data source for syndromic early event detection systems to monitor infectious disease in the prehospital population. It has been previously found that tympanic temperature records can be used to detect influenza outbreaks in emergency departments. This study investigated whether routine tympanic temperature readings collected by ambulance crews can be used to detect seasonal influenza. Here we show that these temperature readings do allow the detection of seasonal influenza before methods applied to conventional data sources. The counts of pyretic patients were used to calculate a sliding case ratio (CR) as a measurement to detect seasonal influenza outbreaks. This method does not rely on conventional thresholds and can be adapted to the data. The data collected correlated with seasonal influenza. The 2016/17 outbreak was detected with high specificity and sensitivity, up to 9 weeks before other surveillance programs. An unanticipated outbreak of E. coli was detected in the same dataset. Our results show that ambulance records can be a useful data source for biosurveillance systems. Two outbreaks caused by different infectious agents have been successfully detected. The routine ambulance records allowed to use tympanic temperature readings that can be used as surveillance tool for febrile diseases. Therefore, this method is a valuable addition to the current surveillance tools.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Reich, T., Budka, M.. 2018-11-09. A proof of concept for a syndromic surveillance system based on routine ambulance records in the South-West of England, for the influenza season 2016/17.. https://doi.org/10.1101/462341

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Thyroid cancer incidence and mortality in Latin America

This study analyzed trends in thyroid cancer incidence and mortality in countries of Latin America. Ecological study of time series, with incidence data extracted from the International Agency for Research on Cancer (IARC), in the 1990-2012 period and mortality data obtained from 16 countries of the World Health Organization (WHO), in the 1995-2013 period. The trend of incidence rate was analyzed by the Joinpoint regression. The average annual percentage change (AAPC) and the 95% confidence interval (CI 95%) were calculated for incidence and mortality. The average rate of thyroid cancer incidence was higher in Quito (Ecuador) between the ages of 40 to 59 years old, 42.2 new cases per 100,000 inhabitants, as well as mortality 4.8 deaths per 100,000 women inhabitants above 60 years old. There was an increase in thyroid cancer incidence trends in women, for all age groups, in Cali, Costa Rica and Quito and men in Costa Rica; there was stability above the age of 60 years old in Cali, Goiania, Quito and Valdivia in men, as well as women in Goiania and Valdivia. There was a trend of increasing mortality for females in three countries: Ecuador (AAPC= 3,28 CI 95% 1,36;5,24), Guatemala (AAPC= 6,14 CI 95% 2,81;9,58) and Mexico (AAPC= 0,67 CI 95% 0,16;1,18). Thyroid cancer in Latin America showed a high incidence, with increased incidence in women. Stability in mortality was observed for most countries of Latin America.

epidemiology

Health seeking behaviour and cost of fever treatment to households in a malaria endemic setting of northern Ghana: A cross sectional study

BackgroundThis study examined the health seeking behaviours and cost of treatment of malaria to households in the Kassena-Nankana district of Ghana.\n\nMethodsA cross-sectional household survey was conducted between July and September 2015. Individuals who had an episode of fever or malaria in the past two weeks identified during routine Health and Demographic Surveillance System data collection were selected for the study. Socio-demographic characteristics, treatment seeking behaviours and cost of treatment of malaria were obtained from the patient perspective.\n\nResultsOut of the 1,845 households visited, 21.3% (393/1,845) reported to have had an episode of fever or malaria in the past two weeks. Of the 393 people with malaria, 66.9% (263/393) reported taking an antimalarial. About 53.6% (141/263) of the antimalarials were obtained from formal healthy facilities. About 36.1% (95/263) reported to have taken Dihydroartemisinin-piperaquine, 35.4 % (93/263) took Artesunate-Amodiaquine and 21.7% (57/263) took Artemether-Lumefantrine. Only 49.6%% (195/393) of the study participants had their blood sample taken for illness (microscopic or Rapid Diagnostic Test). Only 23.6% (62/263) took antimalarial within 24 hours of the onset of illness. The overall average costs (direct and indirect cost) incurred by households per malaria treatment was GH{cents}27.82/US$7.32 (range: GH{cents}0.2/ US$0.05 - GH{cents}200/ US$52.63). The average cost incurred in the treatment of malaria by those who were enrolled into the National Health Insurance Scheme (NHIS) was GH{cents}24.75/US$6.51 and those not enrolled was GH{cents}43.95/US$11.57.\n\nConclusionsPrompt treatment such as treatment within 24 hours of onset of malaria was low. The average costs to households per malaria treatment was GH{cents}27.82/US$7.32 and the preferred antimalarial was Dihydroartemisinin-piperaquine. There was a positive effect of NHIS enrolment on cost of treatment as the insured incurred less cost (US$5 less) in treatment than the uninsured.

epidemiology

Mass media promotion of a smartphone smoking cessation app: Modeled health and cost impacts

BackgroundSmartphones are increasingly available and some high quality apps are available for smoking cessation. However, the cost-effectiveness of promoting such apps has never been studied.\n\nObjectiveTo estimate the health gain, inequality impacts and cost-utility from a five-year promotion campaign of a smoking cessation smartphone app compared to business-as-usual (no app use for quitting).\n\nMethodsA well-established Markov macro-simulation model utilising a multi-state life-table was adapted to the intervention (lifetime horizon, 3% discount rate). The setting was the New Zealand (NZ) population (N = 4.4 million). The intervention effect size was from a multi-country randomised trial: relative risk for quitting at six months = 2.23 (95%CI: 1.08 to 4.77). Intervention costs were based on NZ mass media promotion data and the NZ cost of attracting a smoker to smoking cessation services ($NZ64 per person).\n\nResultsThe five-year intervention was estimated to generate 6760 QALYs (95%UI: 5420 to 8420) over the remaining lifetime of the population. For M[a]ori (Indigenous population) there was 2.8 times the per capita age-standardized QALYs relative to non-M[a]ori. The intervention was also estimated to be cost-saving to the health system (saving NZ$115, 95%UI: 72.5 million [m] to 171m; US$81.8m). The cost-saving aspect of the intervention was maintained in scenario and sensitivity analyses where the discount rate was doubled to 6%, the effect size halved, and the intervention run for just one year.\n\nConclusionsThis study provides modelling-level evidence that mass-media promotion of a smartphone app for smoking cessation is likely to generate health gain, reduce ethnic inequalities in health and save health system costs. Nevertheless, there are other tobacco control which generate considerably larger health gains and cost-savings such as raising tobacco taxes.

epidemiology